drugset / Trial / NCT04419909
Retreatment With CTL019/CTL119
NaSingle-groupOpen-labelTreatment
Summary
This research study is designed to evaluate the effects of retreatment with CTL019/CTL119 in patients with late relapse of B-cell lymphomas.
Timeline
- Start
- 2026-05
- Primary completion
- 2028-07
- Completion
- 2028-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CTL119 | Cell therapy | — | — |
| Subject | Tisagenlecleucel | Cell therapy | — | — |